Answers are grounded in this paper and cite their sources.
Autism spectrum disorder (ASD) is increasingly linked to gut microbial dysbiosis, yet fecal microbiota may not adequately reflect host-microbe interactions at the intestinal mucosa. This study compares colonic in situ and fecal microbiota in children with ASD, evaluates their associations with clinical severity, and examines their responses to washed microbiota transplantation (WMT). Colonic in situ microbiota show marked structural and compositional divergence from fecal microbiota, with limited overlap between compartments. Despite lower microbial diversity, colonic microbiota exhibit broader and stronger associations with ASD severity, including Autism Behavior Checklist (ABC) and Childhood Autism Rating Scale (CARS) scores. In germ-free ASD model mice, transplantation of healthy donor microbiota alleviates autism-like behaviors. Consistently, WMT improves clinical symptoms in children with ASD and progressively shifts colonic microbiota toward donor-like configurations. Colonic microbiota changes are associated with symptom improvement, and exploratory predictive analyses suggest that integrating colonic in situ microbiota with clinical features may provide additional predictive information compared with fecal microbiota-based models. These findings suggest that clinically sampled colonic in situ microbiota may provide complementary information for understanding ASD heterogeneity and treatment response, although further validation is warranted.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: